BAC
GILD icon

Boys Arnold & Co’s Gilead Sciences GILD Stock Holding History

Boys Arnold & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,727
Closed -$1.18M – 74
2020
Q1 		$1.18M Sell
15,727
-372
-2% -$25.7K 0.21% 106
2019
Q4 		$1.05M Sell
16,099
-1,492
-8% -$97.2K 0.14% 127
2019
Q3 		$1.11M Sell
17,591
-7,044
-29% -$460K 0.17% 124
2019
Q2 		$1.66M Sell
24,635
-1,641
-6% -$108K 0.24% 90
2019
Q1 		$1.71M Sell
26,276
-1,900
-7% -$126K 0.26% 87
2018
Q4 		$1.74M Sell
28,176
-892
-3% -$62.3K 0.29% 84
2018
Q3 		$2.27M Sell
29,068
-1,208
-4% -$91.2K 0.31% 82
2018
Q2 		$2.15M Sell
30,276
-2,769
-8% -$196K 0.31% 81
2018
Q1 		$2.44M Sell
33,045
-2,629
-7% -$209K 0.35% 77
2017
Q4 		$2.56M Sell
35,674
-4,752
-12% -$361K 0.38% 68
2017
Q3 		$3.27M Sell
40,426
-1,979
-5% -$151K 0.52% 52
2017
Q2 		$3M Sell
42,405
-6,277
-13% -$418K 0.39% 57
2017
Q1 		$3.31M Sell
48,682
-5,930
-11% -$417K 0.52% 52
2016
Q4 		$3.91M Sell
54,612
-3,707
-6% -$276K 0.65% 41
2016
Q3 		$4.61M Sell
58,319
-277
-0.5% -$22.5K 0.79% 34
2016
Q2 		$4.89M Buy
58,596
+25,052
+75% +$2.22M 0.84% 32
2016
Q1 		$3.08M Sell
33,544
-89,176
-73% -$8.04M 1.22% 18
2015
Q4 		$12.4M Buy
122,720
+60,731
+98% +$6.32M 1.35% 16
2015
Q3 		$6.09M Buy
61,989
+3,101
+5% +$344K 1.27% 16
2015
Q2 		$6.89M Sell
58,888
-2,417
-4% -$264K 1.34% 17
2015
Q1 		$6.02M Sell
61,305
-1,025
-2% -$104K 1.15% 17
2014
Q4 		$5.88M Buy
62,330
+580
+0.9% +$60K 1.14% 21
2014
Q3 		$6.57M Sell
61,750
-8,311
-12% -$814K 1.3% 20
2014
Q2 		$5.81M Buy
70,061
+2,360
+3% +$184K 1% 29
2014
Q1 		$4.8M Sell
67,701
-1,100
-2% -$86.3K 0.87% 36
2013
Q4 		$5.17M Buy
68,801
+2,025
+3% +$141K 0.99% 34
2013
Q3 		$4.2M Buy
66,776
+19,101
+40% +$1.14M 0.87% 39
2013
Q2 		$2.44M Buy
+47,675
New +$2.48M 0.53% 63

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Boys Arnold & Co's GILD Position: Q2 2020 in Review

Boys Arnold & Co sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 15,727 shares — an estimated $1.18M sold.

Boys Arnold & Co first reported a position in GILD in Q2 2013 and held it in 28 quarters. The position peaked at $12.4M in Q4 2015. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Boys Arnold & Co reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Boys Arnold & Co sold 15,727 Gilead Sciences shares in Q2 2020, an estimated $1.18M.
  • Boys Arnold & Co first reported a position in Gilead Sciences in Q2 2013 and held it in 28 quarters.
  • Boys Arnold & Co's Gilead Sciences position peaked at $12.4M in Q4 2015.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Boys Arnold & Co's 13F filing for Q2 2020.